Ascendis Pharma (ASND) PT Raised to $167 at JPMorgan
Tweet Send to a Friend
(Updated - January 29, 2025 9:41 AM EST)
JPMorgan analyst Jessica Fye raised the price target on Ascendis Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Jessica Fye raised the price target on Ascendis Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
